Cargando…
New therapeutic approaches for malignant glioma: in search of the Rosetta stone
Malignant gliomas are heterogeneous, diffuse and highly infiltrating by nature. Despite wide surgical resection and improvements in radio- and chemotherapies, the prognosis of patients with glioblastoma multiforme remains extremely poor, with a median survival time of only 14.5 months from diagnosis...
Autores principales: | Auffinger, Brenda, Thaci, Bart, Nigam, Pragati, Rincon, Esther, Cheng, Yu, Lesniak, Maciej S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438652/ https://www.ncbi.nlm.nih.gov/pubmed/22991580 http://dx.doi.org/10.3410/M4-18 |
Ejemplares similares
-
Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice
por: Auffinger, Brenda, et al.
Publicado: (2013) -
The Rosetta Stone
por: Petsko, Gregory A
Publicado: (2001) -
Inhibition of MMP14 potentiates the therapeutic effect of temozolomide and radiation in gliomas
por: Ulasov, Ilya, et al.
Publicado: (2013) -
Drug-Loaded Nanoparticle Systems And Adult Stem Cells: A Potential Marriage For The Treatment Of Malignant Glioma?
por: Auffinger, Brenda, et al.
Publicado: (2013) -
Back to beginning: Searching for Rosetta Stone of enhancing herbal medicine quality
Publicado: (2021)